Skip to main content
Zydus Wellness Limited logo

Zydus Wellness Limited — Investor Relations & Filings

Ticker · ZYDUSWELL ISIN · INE768C01028 LEI · 335800YCS4FG8P1D1Y21 BSE.NS Manufacturing
Filings indexed 902 across all filing types
Latest filing 2026-06-04 Regulatory Filings
Country IN India
Listing BSE.NS ZYDUSWELL

About Zydus Wellness Limited

https://www.zyduswellness.com/

Zydus Wellness Limited is a consumer wellness organization dedicated to providing products that support a healthy lifestyle. The company manages a portfolio of established brands across several categories, including nutritional supplements, energy drinks, sweeteners, skincare, and healthy spreads. Its core product lineup features Sugar Free, a leading brand in the sugar substitute market; Glucon-D, a prominent glucose-based energy drink; and Complan, a fortified health food drink. Additionally, the portfolio includes Nycil prickly heat powder, Everyuth skincare products, and Nutralite table spreads. The company focuses on product innovation and quality to meet the demands of health-conscious consumers. Through a combination of research-driven development and a comprehensive distribution infrastructure, the entity provides functional wellness solutions designed to enhance the daily lives of its target audience.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 78% confidence The document is a compliance announcement notifying exchanges and publishing statutory newspaper cuttings of a notice to shareholders for transfer of unclaimed shares to the Investor Education and Protection Fund (IEPF) under Section 124(6) of the Companies Act. It is not an annual or quarterly report, nor an earnings release, proxy or voting result, dividend declaration, or other specific category. It is a general regulatory announcement/filing under corporate governance rules, so it falls into Regulatory Filings (RNS).
2026-06-04 English
Newspaper Publication regarding transfer of shares to IEPF
Regulatory Filings Classification · 82% confidence The document is an official compliance notice addressed to stock exchanges, attaching newspaper cuttings of a shareholders’ notice under section 124(6) of the Companies Act regarding transfer of unclaimed shares/dividends to the IEPF. It is neither a financial report nor a dividend payment notice but a regulatory announcement under Indian corporate law. This fits the “Regulatory Filings” (RNS) category for general regulatory/compliance documents.
2026-06-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 98% confidence The document is a disclosure letter under SEBI Listing Obligations (Regulation 30) informing stock exchanges of the company’s participation in an upcoming analyst/institutional investor conference. It contains no financial statements or detailed presentation, and is a regulatory disclosure to the exchanges rather than an annual or interim report, investor presentation, or other substantive filing. It falls under miscellaneous regulatory announcements.
2026-06-02 English
Analyst/ Institutional Investors'' Conference on June 8, 2026
Regulatory Filings Classification · 12% confidence The document is a stock exchange filing under SEBI LODR regulation 30 announcing the schedule for an Analyst/Institutional Investors’ Conference. It is a regulatory announcement, not a substantive financial report, proxy, or dividend notice. Thus, it fits under Regulatory Filings (RNS).
2026-06-02 English
Updates
Director's Dealing Classification · 86% confidence The document is a Form B disclosure under SEBI (Prohibition of Insider Trading) Regulations detailing acquisition of shares by the spouse of a designated person, ie. an insider trading transaction report. This falls squarely under ‘Director’s Dealing’ filings reporting personal or immediate-relative share transactions.
2026-06-02 English
Disclosure under Insider Trading Regulations
Director's Dealing Classification · 93% confidence The document is a statutory disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015 (Form B) reporting an insider (spouse of a designated person) acquiring equity shares. This is a classic insider transaction by a director-level individual, matching the “Director’s Dealing” category. It is not the company buying back shares (POS) nor a broader shareholding notification (MRQ).
2026-06-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.